Skip to main content
. Author manuscript; available in PMC: 2015 Apr 19.
Published in final edited form as: Ann Surg Oncol. 2012 May 2;19(12):3896–3905. doi: 10.1245/s10434-012-2373-8

Figure 4.

Figure 4

Reverse phase protein array (RPPA) analysis. Using linear load-corrected measurements of protein expression, the ratio of phospho-protein to total protein is plotted for 5 patients before and after treatment with sorafenib for MEK (left) and MAPK (right). Tumor tissue was analyzed from two patients from the low-dose (400 mg) sorafenib cohort and 3 patients from the high-dose (600 mg) sorafenib cohort.